Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study
Atsuo Takashima, Pilar García‐Alfonso, Raimundo Manneh, Ali Ayberk Beşen, Yong Sang Hong, Pieter‐Jan Cuyle, Patricio Yañez, Matthew Burge, Takayuki Yoshino, Tae Won Kim, Karen Cui, Chenxiang Li, Rishi Jain, David E. Adelberg, Julien Taı̈eb
Topics & Concepts
BevacizumabOlaparibMedicineOncologyColorectal cancerInternal medicineMaintenance therapyRandomized controlled trialCancerChemotherapyPoly ADP ribose polymeraseBiochemistryPolymeraseChemistryGenePARP inhibition in cancer therapyColorectal Cancer Treatments and StudiesAdvanced Breast Cancer Therapies